Neoantigen-based peptide vaccine Clinical Trials
4 recruitingDrug
Not Applicable3Phase 21
Showing 1–4 of 4 trials
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751966
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751914
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06752044
Recruiting
Phase 2
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751901